JUVEDERM Treatment Visualizer|健康線上App不用買

シェア記事:

【免費健康App】JUVEDERM Treatment Visualizer-APP點子

The JUVÉDERM® Treatment Visualizer is an app geared towards helping you visualize how JUVÉDERM® can smooth away your wrinkles and folds, so you can personalize your treatment. With the JUVÉDERM® Treatment Visualizer you are not just able to visualize how you may look with JUVÉDERM® treatment, but also learn potential questions to ask your doctor and treatment tips that will help you and your doctor at your JUVÉDERM® treatment consultation. And if you don’t have a doctor, don’t worry, as the app will help you find a doctor too.

By simulating the results of JUVÉDERM® treatment, the JUVÉDERM® Treatment Visualizer is the optimal tool to help you decide if you should talk to a doctor about JUVÉDERM® treatment. This app is for demonstrative purposes only. Results may vary.

JUVÉDERM® XC Important Information

Indication

JUVÉDERM® injectable gel is injected into areas of facial tissue where moderate to severe facial wrinkles and folds occur to temporarily add volume to the skin, which may give the appearance of a smoother surface.

IMPORTANT SAFETY INFORMATION

Your physician will ask about your medical history to determine if you are an appropriate candidate for treatment. The product should not be used in patients who have:

• Severe allergies marked by a history of anaphylaxis or history or presence of multiple severe allergies

【免費健康App】JUVEDERM Treatment Visualizer-APP點子

• A history of allergies to lidocaine or Gram-positive bacterial proteins

The safety and effectiveness for the treatment of areas other than facial wrinkles and folds (such as lips) have not been established in controlled clinical studies.

The following are important treatment considerations for you to discuss with your physician and understand in order to help avoid unsatisfactory results and complications:

• Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at injection site. You should inform your physician before treatment if you are using these types of substances

• If laser treatment, chemical peeling, or any other procedure based on active dermal response is considered after treatment with JUVÉDERM®, there is a possible risk of an inflammatory reaction at the treatment site

• JUVÉDERM® injectable gel should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body’s immune response, as there may be an increased risk of infection

• The safety for use during pregnancy, in breast-feeding females, or in patients under 18 years has not been established

• The safety in patients with a history of excessive scarring (e.g., hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied

Most side effects are mild or moderate in nature, and their duration is short lasting (7 days or less). The most common side effects include, but are not limited to, temporary injection-site reactions such as: redness, pain/tenderness, firmness, swelling, lumps/bumps, bruising, itching, and discoloration.

As with all skin-injection procedures, there is a risk of infection.

To report a problem with JUVÉDERM®, please call Allergan Product Surveillance at 1-800-624-4261.

For more information, please see the About Safety page at www.juvederm.com or call the Allergan Product Support line at 1-800-433-8871.

JUVÉDERM® injectable gel is available by prescription only.

©2013 Allergan, Inc. ® and ™ marks owned by Allergan, Inc. JUVÉDERM® mark owned by Allergan Industries SAS.

免費玩JUVEDERM Treatment Visualizer APP玩免費

免費玩JUVEDERM Treatment Visualizer App

JUVEDERM Treatment Visualizer APP LOGO

JUVEDERM Treatment Visualizer LOGO-APP點子

JUVEDERM Treatment Visualizer APP QRCode

JUVEDERM Treatment Visualizer QRCode-APP點子
熱門國家系統支援版本費用APP評分上架日期更新日期
未知Android
Google Play
1.0.0
App下載
免費
1970-01-012015-03-12
未知iOS
App Store
2.0.4
App下載
免費
2012-02-162015-05-29
美國 (U.S.A)iOS
App Store
2.0.2
App下載
免費
2014-06-262014-09-19
シェア記事: